Browsing Category
Covid
Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs
First dose of Oxford-AstraZeneca or Pfizer-BioNTech followed nine weeks later by second dose of Novavax or Moderna COVID-19 vaccines generated a robust immune response.
Oxford-AstraZeneca followed by Moderna/Novavax schedules…
Angstrom Biotech launches India’s First Saliva-Based Home Testing Kit for Covid-19
New Delhi : In light of the COVID-19 pandemic and the commotion, paranoia, and chaos that it has spread in the society, Angstrom Biotech Pvt. Ltd. – one of India’s most renowned and trusted diagnostic equipment manufacturers –…
First Reports of Omicron Reported
It seems like every day; people tune in to the news at dinnertime to hear unpleasant news of some sort. More often than not, this news tends to revolve around COVID. This does make sense though as it is hard to disagree that COVID is now a…
Successful manufacture of Monash’s COVID-19 mRNA vaccine candidate
The first Australian COVID-19 mRNA vaccine candidate, developed by the Monash Institute of Pharmaceutical Sciences (MIPS), has moved a step closer with production reaching a significant development milestone.
Melbourne-based company IDT…
India’s Cumulative COVID-19 Vaccination Coverage exceeds 124.10 Cr
New Delhi: With the administration of 80,98,716vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 124.10 Cr (1,24,10,86,850) as per provisional reports till 7 am today. This has been achieved through…
Statement of RDIF and the Gamaleya Institute on Omicron variant of COVID
Moscow: The Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2 known to date. This has been demonstrated by an article published in Vaccines medical journal and…
EU replaces COVID-19 vaccines export authorisation mechanism with new monitoring tool
The EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021. This means that, as of 1 January 2022, vaccine producers will no longer have to request an authorisation for…
European Commission proposes to strengthen coordination of safe travel in the EU
Today, the European Commission has proposed to update the rules on coordination of safe and free movement in the EU, which were put in place in response to the COVID-19 pandemic.
Since the summer, vaccine uptake has increased…
UK Government takes decisive action against new COVID-19 variant
Temporary and precautionary measures to prevent the spread of the new COVID-19 Omicron variant in the UK will come into force on Tuesday, the government has confirmed.
From 4am Tuesday 30 November face coverings will be compulsory in…
Sputnik V shows 80% long-term efficacy against COVID in San Marino from 6th through 8th month after…
Moscow,: The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective…